Latest Asx News

Locksley Resources has expanded the Desert Antimony Mine target at its Mojave Project by 400%, revealing a new parallel structural zone and boosting the project's potential as a critical U.S. minerals hub.

NSX Limited shareholders overwhelmingly approved a scheme of arrangement for acquisition by 1001290557 Ontario Inc., a related entity of the Canadian Stock Exchange operator CNSX Markets Inc. The deal, valued at four cents per fully paid share, now awaits Federal Court approval to proceed.

Kairos Minerals has finalized a pivotal mineral rights agreement with Pilbara Minerals, granting it extensive rights over key Pilbara licences and setting the stage for a significant drilling campaign to expand its Mt York gold resource.

Triangle Energy (Global) Limited has been awarded a 100% interest in the SC-82 onshore exploration contract in the Philippines’ Cagayan Basin, unlocking a large prospective gas area near existing infrastructure.

Triangle Energy and its joint venture partners have been awarded two offshore service contracts in the underexplored Sandakan Basin, Philippines, holding significant contingent gas and condensate resources. These contracts mark a strategic expansion into a promising region with multi-TCF exploration upside.

Kingsgate Consolidated updates its 2025 Mineral Resources and Ore Reserves, introducing a maiden estimate for the Chatree South-East Complex while reporting modest declines in overall Ore Reserves.

Melbana Energy has significantly upgraded its prospective resource estimates for the AC/P70 offshore permit, boosting gas and oil volumes and advancing the Hadrosaurus lead to prospect status, while progressing a farmout process to fund exploration.

Legacy Minerals has confirmed significant high-grade gold and silver mineralisation at its Mascotte prospect and commenced diamond drilling at the Battery prospect within the Mt Carrington Project in NSW.

Western Mines Group has been awarded a $180,000 government grant to fund further drilling at its Mulga Tank nickel project, targeting a promising komatiite mineral system. This funding supports the company’s ongoing exploration efforts to delineate a significant nickel sulphide deposit in Western Australia.

Prescient Therapeutics has bolstered its cash reserves to $12.3 million following a $9.8 million capital raise, while progressing its PTX-100 cancer therapy through global Phase 2 trials with encouraging early lymphoma results.

Findi Limited has responded to ASX inquiries about unusual stock price and volume movements, denying any undisclosed information and announcing legal action against a former subsidiary executive for misleading social media posts.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.